(firstQuint)Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa.

 Twenty patients with hidradenitis suppurativa will be enrolled and randomised to treatment with either botulinum toxin B or placebo (saline) in affected areas.

 Intervention and recording of data will be performed every three months.

 After three months, all patients will receive active substance.

 After six months, randomization will revealed.

 Patients with clinical improvement will be given the opportunity to continue treatment for additional six months.

.

 Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa@highlight

Randomized double blind placebo controlled pilot study/proof of concept-study to see if intradermal injection with Botulinum toxin B is an effective treatment of Hidradenitis suppurativa